{"id":40299,"date":"2025-04-22T05:57:08","date_gmt":"2025-04-22T05:57:08","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/40299\/"},"modified":"2025-04-22T05:57:08","modified_gmt":"2025-04-22T05:57:08","slug":"can-ai-cure-all-diseases-within-a-decade-nobel-laureate-demis-hassabis-shares-bold-vision-for-the-future-of-medicine","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/40299\/","title":{"rendered":"Can AI cure all diseases within a decade? Nobel laureate Demis Hassabis shares bold vision for the future of medicine"},"content":{"rendered":"

When Sir Demis Hassabis<\/a>, co-founder of Google DeepMind and knighted British AI visionary, isn\u2019t decoding protein structures or redefining the future of medicine, he\u2019s enjoying a good game \u2014 whether it\u2019s chess, poker, or the ultimate intellectual pursuit: artificial intelligence. A man once driven by curiosity about life\u2019s biggest mysteries, Hassabis has turned that fascination into revolutionary breakthroughs that could mark the beginning of the end for human disease.<\/p>\n

In a CBS 60 Minutes clip posted by the Instagram page artificialintelligencenews.in, Hassabis tells CBS\u2019s Scott Pelley something that sounds more like science fiction than science fact: AI, he claims, could help eliminate all diseases within the next ten years.<\/p>\n

Medicine\u2019s Next Leap: Faster, Smarter, and Possibly Final \u201cIt takes, on average, ten years and billions of dollars to develop just one drug,\u201d Hassabis explained. \u201cWe could maybe reduce that down to months, or even weeks.\u201d These are not hollow promises. This is the same scientist whose AI model cracked the code of protein structures \u2014 the essential building blocks of life \u2014 mapping over 200 million structures in a single year. Before DeepMind’s intervention, only 1% of those structures had been deciphered, each taking years to decode.
That same AI prowess is now being aimed at drug development. According to Hassabis, such exponential leaps in research speed could \u201crevolutionize human health.\u201d With a touch of cautious optimism, he adds, \u201cI think one day, maybe we can cure all disease with the help of AI. Maybe within the next decade. I don’t see why not.\u201d
Beyond Intelligence: The Rise of Scientific Imagination While current AI models are still limited by a lack of true curiosity and intuition, Hassabis sees a not-too-distant future where machines won\u2019t just solve scientific problems \u2014 they\u2019ll identify them first. \u201cIn the next five to ten years,\u201d he said, \u201cwe\u2019ll have systems that are capable of coming up with new hypotheses in science on their own.\u201d
This transformative shift won Hassabis and his colleague John Jumper the 2024 Nobel Prize in Chemistry for their groundbreaking work in AI-driven protein structure prediction. Their contributions have already opened new frontiers in biology and medicine. Now, he envisions AI systems becoming imaginative \u2014 capable of independent scientific creativity \u2014 pushing humanity toward what he calls radical abundance, a world without scarcity, and perhaps, without disease.
A Cautious Future: Guardrails and Grand Visions But Hassabis is not blind to AI\u2019s potential risks. He highlights two critical concerns: the misuse of AI by malicious actors, and the challenge of keeping increasingly autonomous AI systems aligned with human values. \u201cCan we make sure they stay on the guardrails?\u201d he asks, referring to the safety protocols baked into AI systems. As a UK Government AI Advisor and the mind behind both DeepMind and Isomorphic Labs, Hassabis is not just leading the charge in AI research \u2014 he\u2019s helping shape policy to ensure AI\u2019s power remains beneficial and secure.A Future Within Reach? Sir Demis Hassabis stands at the crossroads of human knowledge and machine capability. A child prodigy turned global AI authority, his predictions aren\u2019t mere speculation \u2014 they\u2019re grounded in proven scientific progress. As the world grapples with pandemics, drug shortages, and rising healthcare costs, his vision of a disease-free future, driven by AI, offers a breathtaking possibility.
\u201cAI is the ultimate tool for advancing human knowledge,\u201d he says. If he\u2019s right, the future of medicine might not lie in syringes and surgeries \u2014 but in circuits and code.<\/p>\n","protected":false},"excerpt":{"rendered":"When Sir Demis Hassabis, co-founder of Google DeepMind and knighted British AI visionary, isn\u2019t decoding protein structures or…\n","protected":false},"author":2,"featured_media":40300,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[22950,22949,22946,22953,22948,22944,22947,105,4348,22945,22951,22952,16,15],"class_list":{"0":"post-40299","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-ai-advancements-in-healthcare","9":"tag-ai-drug-development","10":"tag-ai-in-medicine","11":"tag-ai-safety-protocols","12":"tag-deepmind-protein-structure","13":"tag-demis-hassabis","14":"tag-future-of-healthcare","15":"tag-health","16":"tag-healthcare","17":"tag-human-disease-eradication","18":"tag-nobel-prize-in-chemistry-2024","19":"tag-scientific-creativity-ai","20":"tag-uk","21":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114380081978457664","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/40299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=40299"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/40299\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/40300"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=40299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=40299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=40299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}